BioSpace News Archive

Tiziana Life Sciences plc (“Tiziana”, AIM: TILS, NASDAQ: TLSA), announces a ratio change to its sponsored Level 3 American Depositary Receipt (“ADR”) programme.

Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first patients have started treatment in its Phase II study evaluating the safety and efficacy of its investigational antibody-drug conjugate (ADC) [vic-]trastuzumab duocarmazine (SYD985) in patients with HER2-expressing recurrent, advanced or metastatic endometrial (uterine) cancer.

CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) and Laboratoire LSL Inc. (“Laboratoire LSL”) announce that the parties have terminated their contractual relationship for the acquisition of the securities of Laboratoire LSL announced by press release on March 27, 2020.

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that a new peer-reviewed study demonstrates the utility of incorporating Remote Electrical Neuromodulation (REN) into usual care of chronic migraine.

Dr. Vladimir Zelenko, a New York based primary care physician, announced that a retrospective analysis based on his patient data is available to read online at www.thezelenkoprotocol.com.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its customer, Vanderbilt University Medical Center (VUMC) published positive preclinical results using potently neutralizing antibodies as a potential therapy for preventing and treating COVID-19 in humans.

As a growing amount of COVID-19 antibody tests are being administered, antibody testing efficiency is increasingly critical. Premier Medical Laboratory Services (PMLS), a leading commercial diagnostic laboratory, has found a way to increase their antibody testing capacity to now process 50,000 per day while decreasing their turnaround time - providing results in under 48 hours.

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2020 of $0.74 per share on outstanding common stock.

Wright Medical Group N.V. (NASDAQ: WMGI) today announced that the first shoulder arthroplasty procedure was performed using groundbreaking BLUEPRINT Mixed Reality Technology at Mayo Clinic’s campus in Rochester, Minnesota.

Cytokinetics, Incorporated (Nasdaq:CYTK) today announced plans to offer, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering